Adaptimmune Therapeutics PLC (ADAP)

11.05 +6.19  +127.37% NASDAQ May 29, 16:58 Delayed 2m USD

Adaptimmune Therapeutics Revenue (Quarterly):

0.761M for March 31, 2020
View 4,000+ financial data types
View Full Chart

Revenue (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Revenue (Quarterly) Data

View and export this data going back to 2014. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 0.761M
Dec. 31, 2019 0.728M
Sept. 30, 2019 0.237M
June 30, 2019 0.157M
March 31, 2019
Dec. 31, 2018 1.479M
Sept. 30, 2018 40.79M
June 30, 2018 9.038M
March 31, 2018 8.196M
Dec. 31, 2017 4.27M
Sept. 30, 2017 27.18M
June 30, 2017 3.521M
March 31, 2017 2.857M
Dec. 31, 2016 8.536M
Sept. 30, 2016 2.416M
June 30, 2016 0.328M
March 31, 2016 2.918M
Sept. 30, 2015 3.940M
Dec. 31, 2014 2.268M
Sept. 30, 2014 1.533M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Benchmarks

Mereo BioPharma Group PLC --
Verona Pharma PLC --
Autolus Therapeutics PLC 0.338M

Revenue (Quarterly) Range, Past 5 Years

Minimum 0.157M Jun 2019
Maximum 40.79M Sep 2018
Average 6.904M



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.